Comparison between Claris Lifesciences IPO and RPP Infra Projects IPO.
Claris Lifesciences IPO is a Mainboard Bookbuilding IPO proposed to list at BSE while RPP Infra Projects IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Claris Lifesciences IPO is up to ₹300.00 Cr whereas the issue size of the RPP Infra Projects IPO is up to ₹48.75 Cr. The final issue price of Claris Lifesciences IPO is ₹228.00 per share and of RPP Infra Projects IPO is ₹75.00 per share.
| Claris Lifesciences IPO | RPP Infra Projects IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹228.00 per share | ₹68.00 per share |
| Issue Price (Upper) | ₹235.00 per share | ₹75.00 per share |
| Issue Price (Final) | ₹228.00 per share | ₹75.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ₹0.00 per share | |
| Market Lot Size | 22 shares | 80 shares |
| Fresh Issue Size | 1,26,32,477 shares | 61,00,584 shares |
| Fresh Issue Size (Amount) | up to ₹300.00 Cr | up to ₹45.75 Cr |
| OFS Issue Size | 0 shares | 4,00,000 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹3.00 Cr |
| Issue Size Total | 1,26,32,477 shares | 65,00,584 shares |
| Issue Size Total (Amount) | up to ₹300.00 Cr | up to ₹48.75 Cr |
Claris Lifesciences IPO opens on Nov 24, 2010, while RPP Infra Projects IPO opens on Nov 18, 2010. The closing date of Claris Lifesciences IPO and RPP Infra Projects IPO is Dec 02, 2010, and Nov 22, 2010, respectively.
| Claris Lifesciences IPO | RPP Infra Projects IPO | |
|---|---|---|
| Anchor Bid Date | Nov 23, 2010 | |
| Issue Open | Nov 24, 2010 | Nov 18, 2010 |
| Issue Close | Dec 02, 2010 | Nov 22, 2010 |
| Basis Of Allotment (Tentative) | ||
| Initiation of Refunds (Tentative) | ||
| Credit of Share (Tentative) | ||
| Listing date (Tentative) | Dec 20, 2010 | Dec 06, 2010 |
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
Claris Lifesciences IPO P/E ratio is , as compared to RPP Infra Projects IPO P/E ratio of .
| Claris Lifesciences IPO | RPP Infra Projects IPO | |||||
|---|---|---|---|---|---|---|
| Financials | Company Financials ()
| Company Financials ()
| ||||
| Promoter Shareholding (Pre-Issue) | 86.03 | 99.99 | ||||
| Promoter Shareholding (Post-Issue) | 0.69 | 71.23 | ||||
| P/E Ratio | ||||||
| Market Cap | ₹1455.05 Cr. | ₹169.50 Cr. | ||||
| ROE | ||||||
| ROCE | ||||||
| Debt/Equity | ||||||
| EPS | ||||||
| RoNW | 24.15 | 33.66 |
In the Claris Lifesciences IPO Retail Individual Investors (RII) are offered 37,89,743 shares while in RPP Infra Projects IPO retail investors are offered 37,89,743 shares. Qualified Institutional Buyers (QIB) are offered 57,36,484 shares in Claris Lifesciences IPO and 30,50,000 shares in RPP Infra Projects IPO.
| Claris Lifesciences IPO | RPP Infra Projects IPO | |
|---|---|---|
| Anchor Investor Reservation | 18,43,003 shares | |
| Market Maker Reservation | ||
| QIB | 57,36,484 shares | 30,50,000 shares |
| NII | 12,63,247 shares | 9,15,000 shares |
| RII | 37,89,743 shares | 21,35,000 shares |
| Employee | 4,00,000 shares | |
| Others | ||
| Total | 1,26,32,477 shares | 65,00,000 shares |
Claris Lifesciences IPO subscribed 1.05x in total, whereas RPP Infra Projects IPO subscribed 2.96x.
| Claris Lifesciences IPO | RPP Infra Projects IPO | |
|---|---|---|
| QIB (times) | 1.04x | 0.16x |
| NII (times) | 1.72x | 7.27x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 1.35x | 5.60x |
| Employee (times) | 0.43x | |
| Other (times) | ||
| Total (times) | 1.05x | 2.96x |
